Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral 5-ASA Withdrawal in Inactive Ulcerative Colitis
NCT02537210Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Sep 2015
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in ulcerative colitis (UC) comparing Mesalazine Maintenance with Placebo Withdrawal (2 arms). Primary endpoint: Clinical Relapse Rate at 12 months. Started Sep 2015; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02537210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537210.